World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
47
Citations
10080
World Ranking
6125
National Ranking
625

Overview

Tom P. Freeman is affiliated with the University of Bath in the United Kingdom. Their research primarily focuses on the field of Medicine, with specific emphasis on Pharmacology, Psychiatry and Mental Health, Epidemiology, Toxicology, and Pediatrics, Perinatology and Child Health.

Their work covers various topics related to substance use, mental health, and drug analysis. Key research topics include:

  • Cannabis and Cannabinoid Research
  • Substance Abuse Treatment and Outcomes
  • Forensic Toxicology and Drug Analysis
  • Bipolar Disorder and Treatment
  • Prenatal Substance Exposure Effects
  • Homelessness and Social Issues
  • Schizophrenia Research and Treatment

Freeman has published extensively, frequently contributing to journals such as:

  • Addiction
  • bioRxiv (Cold Spring Harbor Laboratory)
  • International Journal of Drug Policy
  • Psychological Medicine
  • Journal of Psychopharmacology

Co-authorship collaborations have been a significant part of Freeman's research output. Regular collaborators include:

  • Will Lawn
  • Claire Mokrysz
  • Rachel Lees
  • Kat Petrilli
  • Chandni Hindocha

Notable recent papers authored or co-authored by Freeman include:

  • Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis, 2020, Addiction
  • Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial, 2020, The Lancet Psychiatry

Other significant studies within the data set, though not authored by Freeman, highlight the broader research context in which their work is positioned.

Best Publications

  • The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

    Marta Di Forti;Marta Di Forti;Marta Di Forti;Diego Quattrone;Diego Quattrone;Diego Quattrone;Tom P. Freeman;Giada Tripoli

  • New trends in cannabis potency in USA and Europe during the last decade (2008-2017).

    Suman Chandra;Mohamed M Radwan;Chandrani G Majumdar;James C Church

  • Keep off the grass? Cannabis, cognition and addiction

    H. Valerie Curran;Tom P. Freeman;Claire Mokrysz;David A. Lewis

  • Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study

    Celia J A Morgan;Gráinne Schafer;Tom P Freeman;H Valerie Curran

  • Examining the profile of high-potency cannabis and its association with severity of cannabis dependence.

    T. P. Freeman;Adam Winstock

  • Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis.

    Tom P. Freeman;Tom P. Freeman;Sam Craft;Sam Craft;Jack Wilson;Stephan Stylianou

  • Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis.

    Celia J A Morgan;Tom P Freeman;Gráinne L Schafer;H Valerie Curran

  • Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials.

    Edward Chesney;Dominic Oliver;Alastair Green;Simina Sovi

  • Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being.

    C.J.A. Morgan;C. Gardener;G. Schafer;S. Swan

  • Medicinal use of cannabis based products and cannabinoids

    Tom P Freeman;Chandni Hindocha;Chandni Hindocha;Sebastian F Green;Michael A P Bloomfield

  • The neuropsychopharmacology of cannabis: a review of human imaging studies

    Michael A.P. Bloomfield;Chandni Hindocha;Sebastian F. Green;Matthew B. Wall

  • How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review

    Abigail M. Freeman;Katherine Petrilli;Rachel Lees;Chandni Hindocha

  • 'Standard THC units': a proposal to standardize dose across all cannabis products and methods of administration.

    Tom P Freeman;Tom P Freeman;Tom P Freeman;Valentina Lorenzetti

  • Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial.

    Tom P Freeman;Chandni Hindocha;Chandni Hindocha;Gianluca Baio;Natacha D C Shaban

  • No Smoke without Tobacco: A Global Overview of Cannabis and Tobacco Routes of Administration and Their Association with Intention to Quit

    Chandni Hindocha;Tom P. Freeman;Jason A. Ferris;Michael T. Lynskey

  • Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence.

    Lindsey A Hines;Tom P Freeman;Tom P Freeman;Suzanne H Gage;Stanley Zammit;Stanley Zammit

  • Association of cannabis potency with mental ill health and addiction: a systematic review

    Unknown

  • Can we make cannabis safer

    Amir Englund;Tom P Freeman;Robin M Murray;Philip McGuire

  • Just say 'know': How do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?

    Tom P. Freeman;Celia J. A. Morgan;Celia J. A. Morgan;Chandni Hindocha;Gráinne Schafer

  • Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users

    Chandni Hindocha;Tom P. Freeman;Grainne Schafer;Chelsea Gardener

  • Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses.

    Will Lawn;Tom P. Freeman;Rebecca A. Pope;Alyssa Joye

Frequent Co-Authors

Chandni Hindocha
Chandni Hindocha Beckley Foundation
Celia J. A. Morgan
Celia J. A. Morgan University of Exeter
H. Valerie Curran
H. Valerie Curran University College London
Michael T. Lynskey
Michael T. Lynskey King's College London
Ulrich Reininghaus
Ulrich Reininghaus Heidelberg University
Cathryn M. Lewis
Cathryn M. Lewis King's College London
Celso Arango
Celso Arango Complutense University of Madrid
Marta Di Forti
Marta Di Forti King's College London
Julio Bobes
Julio Bobes University of Oviedo
Valentina Lorenzetti
Valentina Lorenzetti Australian Catholic University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees in psychology opens the door to a variety of rewarding career pathways, especially in counseling and education. Many students consider becoming school counselors, a profession that offers a direct way to make a positive impact on young people’s lives. However, it’s important to understand that requirements can vary greatly depending on the state.

For instance, if you're interested in learning how to become a school counselor in Texas, you’ll need a master’s degree in counseling and specific certifications unique to Texas. In comparison, Utah has its own set of guidelines, which are detailed under the Utah school counselor education requirements.

The path to school counseling is also unique in Vermont, where students can review the steps outlined in how to become a school counselor in Vermont. Likewise, the Virginia school counselor education requirements highlight the differences in coursework, licensing, and supervised experience.

With online degrees now widely accepted and flexible, pursuing a career in psychology—from clinical practice to school counseling—is more accessible than ever.

Best Scientists Citing Tom P. Freeman

Trending Scientists

Recently Published Articles